Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 13

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

277

HTML

2982

Figures (1-3)

161

Tables (1-2)

111

Sum=3531

Jul 1, 2004 (publication date) through Apr 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Jul 1, 2004; 10(13): 1881-1884
Published online Jul 1, 2004. doi: 10.3748/wjg.v10.i13.1881

Table 1 Clinical characteristics of 14 patients assigned to treat-ment with transjugular intrahepatic portosystemic stent-shunt procedure

Characteristic	Value
Age (yr)
Range	28-75
mean ± SD	53.6 ± 12.7
Sex (M/F)	13/1
Occlusion of portal vein
Portal vein trunk (complete/incomplete)	10/4
Right branch (complete/incomplete)	10/1
Left branch (complete/incomplete)	2/2
Tumor type (nodular/massive/diffuse)	2/6/6
With cavernous transformation of PV	5
Times of TACE (mean ± SD)	3.7 ± 1.8

Citation: Jiang ZB, Shan H, Shen XY, Huang MS, Li ZR, Zhu KS, Guan SH. Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis. World J Gastroenterol 2004; 10(13): 1881-1884
URL: https://www.wjgnet.com/1007-9327/full/v10/i13/1881.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i13.1881